Headlines
•Trump Iran ceasefire maneuver pauses war deadline — Brent crude tops $111, signaling higher-for-longer oil regime
•SOBR Safe announces merger with Clean World Ventures — shares surge 33.7% after hours despite weak Q1 results
•RBC Capital Lifts PT BioCryst Pharmaceuticals (BCRX) as Part of Q1 2026 Results Preview in Biotech
•Neurocrine Biosciences (NBIX) Announces First Presentation of New Two-Year Data From Phase 3 CAHtalyst Adult Study
•Zoetis Inc. (ZTS) Announces Expansion of Capabilities of Vetscan OptiCell
•Why Eli Lilly and Company (LLY) is One of the Best Drug Stocks to Buy According to Analysts
•Lazard agrees $575m Campbell Lutyens acquisition to form private capital arm